Steven P. Luckman

5.2k citations

16 papers · 4.3k indexed · 5 hit papers · h-index 12

Oncology top 0.5%
Orthopedics and Sports Medicine top 0.2%
Molecular Biology top 5%
Radiology, Nuclear Medicine and Imaging top 1%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Michael J. Rogers Fraser P. Coxon R.G.G. Russell Helena L. Benford Julie C. Frith Jukka Mönkkönen D. E. Hughes Sharon Gordon
Topics: Bone health and treatments (8 papers)Myasthenia Gravis and Thymoma (6 papers)Antifungal resistance and susceptibility (5 papers)
Cited by: Orthopedics and Sports Medicine Oncology Radiology, Nuclear Medicine and Imaging
Journals: Proceedings of the National Academy of SciencesSHILAP Revista de lepidopterologíaCancer
Partner nations: United Kingdom Norway Netherlands

In The Last Decade

Steven P. Luckman

16 papers receiving 4.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras

1998 977 citations Steven P. Luckman, D. E. Hughes et al. Journal of Bone and Mineral Research profile →
Structure-Activity Relationships for Inhibition of Farnesyl Diphosphate Synthase in Vitro and Inhibition of Bone Resorption in Vivo by Nitrogen-Containing Bisphosphonates

2001 726 citations James E. Dunford, Keith Thompson et al. Journal of Pharmacology and Experimental Therapeutics profile →
Cellular and molecular mechanisms of action of bisphosphonates

2000 720 citations Michael J. Rogers, Sharon Gordon et al. Cancer profile →
Cellular and molecular mechanisms of action of bisphosphonates

2000 571 citations Michael J. Rogers, Sharon Gordon et al. Cancer profile →
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

1999 570 citations John Fisher, Michael J. Rogers et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Steven P. Luckman

Since Specialization

Citations

This map shows the geographic impact of Steven P. Luckman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven P. Luckman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven P. Luckman more than expected).

Fields of papers citing papers by Steven P. Luckman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven P. Luckman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven P. Luckman. The network helps show where Steven P. Luckman may publish in the future.

Co-authorship network of co-authors of Steven P. Luckman

This figure shows the co-authorship network connecting the top 25 collaborators of Steven P. Luckman. A scholar is included among the top collaborators of Steven P. Luckman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven P. Luckman. Steven P. Luckman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Matrix Metalloproteinases in Myasthenia Gravis 2011 ·European Neurology ·(unknown),Axel Petzold,Steven P. Luckman,Nils Erik Gilhus,Gordon T. Plant,Fredrik Romi	16
2	Matrix Metalloproteinase-3 in Myasthenia Gravis Compared to Other Neurological Disorders and Healthy Controls 2011 ·SHILAP Revista de lepidopterología ·Steven P. Luckman,Nils Erik Gilhus,Fredrik Romi	15
3	Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis 2008 ·Journal of Neuroimmunology ·Fredrik Romi,Nils Erik Gilhus,Steven P. Luckman	10
4	Myasthenia gravis sera have no effect on cardiomyocytes in vitro 2008 ·Journal of Neuroimmunology ·(unknown),Steven P. Luckman,Fredrik Romi,Anne K. Jonassen,Nils Erik Gilhus	4
5	Effects of myasthenia gravis patient sera on human myoblast cultures 2006 ·Acta Neurologica Scandinavica ·Steven P. Luckman,Geir Skeie,(unknown),Nils Erik Gilhus	1
6	Morphological effects of myasthenia gravis patient sera on human muscle cells 2005 ·Muscle & Nerve ·Steven P. Luckman,Geir Skeie,(unknown),Nils Erik Gilhus	8
7	Nitrogen-Containing Biphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras 2005 ·Journal of Bone and Mineral Research ·Steven P. Luckman,D. E. Hughes,Fraser P. Coxon,R.G.G. Russell,Michael J. Rogers	12
8	Partial characterization of cell-type X collagen interactions 2003 ·Biochemical Journal ·Steven P. Luckman,(unknown),Alvin P.L. Kwan	34
9	Structure-Activity Relationships for Inhibition of Farnesyl Diphosphate Synthase in Vitro and Inhibition of Bone Resorption in Vivo by Nitrogen-Containing Bisphosphonatesbreakdown → 2001 ·Journal of Pharmacology and Experimental Therapeutics ·James E. Dunford,Keith Thompson,Fraser P. Coxon,Steven P. Luckman,Frederick M. Hahn,C. Dale Poulter,Frank H. Ebetino,Michael J. Rogers	726
10	Cellular and molecular mechanisms of action of bisphosphonatesbreakdown → 2000 ·Cancer ·Michael J. Rogers,Sharon Gordon,Helena L. Benford,Fraser P. Coxon,Steven P. Luckman,Jukka Mönkkönen,Julie C. Frith	720
11	Cellular and molecular mechanisms of action of bisphosphonatesbreakdown → 2000 ·Cancer ·Michael J. Rogers,Sharon Gordon,Helena L. Benford,Fraser P. Coxon,Steven P. Luckman,Jukka Mönkkönen,Julie C. Frith	571
12	Molecular mechanisms of action of bisphosphonates 1999 ·Bone ·Michael J. Rogers,Julie C. Frith,Steven P. Luckman,Fraser P. Coxon,Helena L. Benford,Jukka Mönkkönen,Seppo Auriola,(unknown),R.G.G. Russell	181
13	Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitrobreakdown → 1999 ·Proceedings of the National Academy of Sciences ·John Fisher,Michael J. Rogers,(unknown),Steven P. Luckman,(unknown),P. Masarachia,Gregg Wesolowski,R.G.G. Russell,Gideon A. Rodan,A A Reszka	570
14	The pharmacology of bisphosphonates and new insights into their mechanisms of action 1999 ·Journal of Bone and Mineral Research ·R.G.G. Russell,Michael J. Rogers,Julie C. Frith,Steven P. Luckman,Fraser P. Coxon,Helena L. Benford,Peter I. Croucher,C M Shipman,H. Fleisch	206
15	Heterocycle-Containing Bisphosphonates Cause Apoptosis and Inhibit Bone Resorption by Preventing Protein Prenylation: Evidence from Structure-Activity Relationships in J774 Macrophages 1998 ·Journal of Bone and Mineral Research ·Steven P. Luckman,Fraser P. Coxon,Frank H. Ebetino,R.G.G. Russell,Michael J. Rogers	222
16	Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Rasbreakdown → 1998 ·Journal of Bone and Mineral Research ·Steven P. Luckman,D. E. Hughes,Fraser P. Coxon,R.G.G. Russell,Michael J. Rogers	977

About Steven P. Luckman

Steven P. Luckman is a scholar working on Neurology, Orthopedics and Sports Medicine and Oncology, having authored 16 papers that have together received 4.3k indexed citations. Recurring topics across this work include Bone health and treatments (8 papers), Myasthenia Gravis and Thymoma (6 papers) and Antifungal resistance and susceptibility (5 papers). The work is most often cited by research in Orthopedics and Sports Medicine (1.8k citations), Oncology (3.4k citations) and Radiology, Nuclear Medicine and Imaging (920 citations). Steven P. Luckman has collaborated with scholars based in United Kingdom, Norway and Netherlands. Frequent co-authors include Michael J. Rogers, Fraser P. Coxon, R.G.G. Russell, Helena L. Benford, Julie C. Frith, Jukka Mönkkönen, D. E. Hughes, Sharon Gordon, Frank H. Ebetino and Keith Thompson. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact